
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions β written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Osteomyelitis laboratory findings
Introduction
Overview
Overview
Laboratory findings in osteomyelitis include increased acute phase reactants (ESR and CRP) levels and leukocytosis.[1] Blood cultures should be performed in all suspected cases. Bone probing and direct sampling is a reliable method, especially in diabetic ulcers which are contaminated with many flora.
Laboratory Findings
Laboratory Findings
Microbiology and histopathology are essential for diagnosis and determining treatment of osteomyelitis.
- Histopathology of bone biopsy samples typically provides the most accurate diagnosis.
- Blood cultures are typically more reliable for hematogenous or vertebral osteomyelitis.
- Samples obtained from swabbing sinus tracts should not be used as the isolate may be contaminated with non-pathogenic microorganisms.
Isolation techniques to determine the causative agent include:
- Blood cultures
- Bone biopsy (which is then cultured)
Laboratory tests to determine infection include:[2][3]
- Complete blood count (CBC)
- C-reactive protein (CRP)
- Erythrocyte sedimentation rate (ESR)
- Note: white blood cell count (WBC) is typically normal and therefore not reliable
References
References
- β PÀÀkkΓΆnen M, Kallio MJ, Kallio PE, Peltola H (2010). “Sensitivity of erythrocyte sedimentation rate and C-reactive protein in childhood bone and joint infections”. Clin. Orthop. Relat. Res. 468 (3): 861β6. doi:10.1007/s11999-009-0936-1. PMCΒ 2816763. PMIDΒ 19533263.
- β Unkila-Kallio L, Kallio MJ, Eskola J, Peltola H (1994). “Serum C-reactive protein, erythrocyte sedimentation rate, and white blood cell count in acute hematogenous osteomyelitis of children”. Pediatrics. 93 (1): 59β62. PMIDΒ 8265325.
- β Cavanagh PR, Lipsky BA, Bradbury AW, Botek G (2005). “Treatment for diabetic foot ulcers”. Lancet. 366 (9498): 1725β35. doi:10.1016/S0140-6736(05)67699-4. PMIDΒ 16291067.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nate Michalak, B.A., Seyedmahdi Pahlavani, M.D. [2]
